Feb 24, 2026 10:23AM
Dec 8, 2025 08:59AM
Nov 12, 2024 04:05PM
Sep 12, 2024 10:39AM
May 13, 2024 12:31PM
Nov 9, 2023 08:00AM
Aug 22, 2023 07:23AM Stifel Upgrades Fulcrum Therapeutics (FULC) to Buy, PT $11, 'Resolution To FTX-6058 Clinical Hold Reintroduces Important Value Driver'
Mar 10, 2023 01:12PM
Aug 16, 2022 07:05AM
Aug 16, 2022 07:05AM
Aug 16, 2022 05:57AM
Aug 15, 2022 09:28PM
Aug 15, 2022 09:28PM
Aug 15, 2022 04:08PM Fulcrum Therapeutics Inc. (FULC) Announces $75M Proposed Public Offering of Common Stock
Aug 15, 2022 04:08PM
Aug 15, 2022 04:08PM
Jul 12, 2022 05:59AM
May 27, 2022 06:07AM
Apr 12, 2022 04:43PM
Mar 29, 2022 05:22PM
Mar 24, 2022 05:15PM Stifel Reiterates Buy Rating on Fulcrum Therapeutics (FULC) With $43 PT, Sees Losmapimod Trial as a "Meaningful Binary Catalyst for the Stock"
Mar 3, 2022 12:44PM
Feb 10, 2022 04:31AM
Jan 6, 2022 12:04PM
Dec 2, 2021 06:33AM
Nov 3, 2021 07:00AM
Nov 3, 2021 07:00AM
Aug 16, 2021 04:01PM Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Aug 16, 2021 04:01PM
Aug 12, 2021 05:46AM
Aug 11, 2021 10:09PM
Aug 11, 2021 10:09PM
Aug 10, 2021 04:24PM
Aug 10, 2021 04:24PM
Aug 10, 2021 04:24PM Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
Aug 10, 2021 01:34PM
Aug 10, 2021 11:00AM
Jul 22, 2021 06:39AM
Jun 24, 2021 10:26AM
May 7, 2021 01:29PM
Mar 1, 2021 04:11PM
Nov 13, 2020 07:30AM Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
Nov 13, 2020 07:30AM
Nov 13, 2019 08:01AM
Nov 13, 2019 08:01AM

41,487 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All